Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.

Bryce B ReeveMolly McFatrichJennifer W MackLaura C PinheiroShana S JacobsJustin N BakerJanice S WithycombeLi LinCourtney M MannKatie R VillabrozaPamela S Hinds

Published in: Pediatric blood & cancer (2020)

In a large, diverse sample of children and adolescents with cancer, there was strong evidence for the construct validity and responsiveness of the PROMIS Pediatric measures. This evidence supports PROMIS Pediatric measure use in pediatric oncology trials.

Keyphrases

patient reported outcomes
childhood cancer
palliative care
squamous cell carcinoma
papillary thyroid
young adults